Primary hyperoxaluria;Hyperoxalurie primitive

Nephrologie et Therapeutique

Volumn 7, Issue 4, 2011, Pages 249-259

  Cochat, Pierre ^a,b,c   Fargue, Sonia ^a,b,c   Bacchetta, Justine ^a,b,c   Bertholet Thomas, Aurélia ^a   Sabot, Jean Franois ^a,b,c   Harambat, Jérôme ^a,b,c  

^a HOSPICES CIVILS DE LYON   (France)

^b INSERM   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Combined liver and kidney transplantation; Nephrocalcinosis; Nephrolithiasis; Oxalosis; Primary hyperoxaluria; Pyridoxin

Indexed keywords

OXALIC ACID; PYRIDOXINE;

ARTICLE; DRUG SAFETY; GENOTYPE; GLOMERULUS FILTRATION RATE; HEPATOCYTE TRANSPLANTATION; HUMAN; HYDRATION; HYPEROXALURIA; KIDNEY CALCIFICATION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; NEPHROLITHIASIS; OXALOSIS 1; PRENATAL DIAGNOSIS; RENAL REPLACEMENT THERAPY; URINE LEVEL;

EID: 79960200435     PISSN: 17697255     EISSN: 18729177     Source Type: Journal    
DOI: 10.1016/j.nephro.2011.03.004     Document Type: Short Survey

References (52)

1. P. Cochat, A. Deloraine, M. Rotily, F. Olive, I. Liponski, N. Deris On behalf of the Société de néphrologie and the Société de néphrologie pédiatrique Epidemiology of primary hyperoxaluria type 1 Nephrol Dial Transplant 10 Suppl. 8 1995 3 7
2. L.C. Cao, T.W. Honeyman, R. Cooney, L. Kennington, C.R. Scheid, and J.A. Jonassen Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity Kidney Int 66 2004 1890 1900 (Pubitemid 41094313)
3. H.K. Koul, and S. Koul Role of p38 MAP kinase signal transduction in oxalate and calcium-oxalate monohydrate crystal induced apoptosis and survival of renal epithelial cells J Am Soc Nephrol 14 2003 339A [abstract]
4. T. Umekawa, N. Chegini, and S.R. Khan Oxalate ions and calcium oxalate crystals stimulates MCP-1 expression by renal epithelial cells Kidney Int 61 2002 105 112 (Pubitemid 34075136)
5. P. Cochat, P. Koch Nogueira, A. Mahmoud, N.V. Jamieson, J.I. Scheinman, and M.O. Rolland Primary hyperoxaluria in infants: medical, ethical and economic issues J Pediatr 135 1999 746 750 (Pubitemid 30180425)
6. P. Cochat, A. Liutkus, S. Fargue, O. Basmaison, B. Ranchin, and M.O. Rolland Primary hyperoxaluria type 1: still challenging! Pediatr Nephrol 21 2006 1075 1081 (Pubitemid 44083878)
7. D.R. Singh, S.N. Sagade, M.H. Kamat, R.B. Deshpande, and B.V. Shah Oxalosis with nephrocalcinosis Nephrol Dial Transplant 15 2000 124 125 (Pubitemid 30037946)
8. P. Cochat, and M.O. Rolland The primary hyperoxalurias A.M. Davison, J.S. Cameron, J.P. Grünfeld, C. Ponticelli, E. Ritz, Oxford textbook of clinical nephrology. 2005 Oxford University Press Oxford 2374-2380
9. M. Marangella, C. Vitale, M. Petrarulo, A. Tricerri, E. Cerelli, and A. Cadario Bony content of oxalate in patients with primary hyperoxaluria or oxalosis-unrelated renal failure Kidney Int 48 1995 182 187
10. B. Behnke, M.J. Kemper, H.P. Kruse, and D.E. Müller-Wiefel Bone mineral density in children with primary hyperoxaluria type 1 Nephrol Dial Transplant 16 2001 2236 2239 (Pubitemid 33062150)
11. M.A. Bogle, C.F. Teller, C.F. Tschen, C.A. Smith, and A. Wang Primary hyperoxaluria in a 27-year-old woman J Am Acad Dermatol 49 2003 725 728 (Pubitemid 37210294)
12. O. Basmaison, M.O. Rolland, P. Cochat, and D. Bozon Identification of 5 novel mutations in the AGXT gene Hum Mutat 15 2000 577 580
13. F. Chevalier-Porst, M.O. Rolland, P. Cochat, and D. Bozon Maternal isodisomy of the telomeric end of chromosome 2 is responsible for a case of primary hyperoxaluria type 1 Am J Med Genet 132A 2005 80 83 (Pubitemid 40070567)
14. C. Danpure, and G. Rumsby Proceedings of the 8th international primary hyperoxaluria workshop, UCL-Institute of Child Health, 29-30 June 2007 Urol Res 35 2007 253 275
15. C.S. Van Woerden, J.W. Groothoff, F.A. Wijburg, C. Annink, R.J. Wanders, and H.R. Waterham Clinical implications of mutation analysis in primary hyperoxaluria type 1 Kidney Int 66 2004 746 752 (Pubitemid 38982018)
16. E. Salido Transgenic AGTKO mouse as a model system Urol Res 35 2007 259
17. C.Y. Pak, B. Adams-Huet, J.R. Poindexter, M.S. Pearle, R.D. Peterson, and O.W. Moe Relative effect of urinary calcium and oxalate on saturation of calcium oxalate Kidney Int 66 2004 2032 2037
18. M. Marangella, M. Petrarulo, D. Cossedu, C. Vitale, and F. Linari Oxalate balance studies in patients on hemodialysis for type I primary hyperoxaluria Am J Kidney Dis 19 1992 546 553
19. M. Mydlik, and K. Derzsiova Renal replacement therapy and secondary hyperoxalemia in chronic renal failure Kidney Int 78 2001 S304 S307 [suppl]
20. B. Hoppe, M. Kemper, A. Bökenkamp, A. Portale, R. Cohn, and C. Langman Plasma calcium oxalate super saturation in children with primary hyperoxaluria and end-stage renal failure Kidney Int 56 1999 268 274 (Pubitemid 29300544)
21. T. Yamauchi, M. Quillard, S. Takahasi, and M. Nguyen-Khoa Oxalate removal by daily dialysis in a patient with primary hyperoxaluria type 1 Nephrol Dial Transplant 16 2001 2407 2411 (Pubitemid 33133855)
22. C.F. Franssen Oxalate clearance by haemodialysis: a comparison of seven dialysers Nephrol Dial Transplant 20 2005 1916 1921 (Pubitemid 41222608)
23. C.G. Monico, S. Rossetti, J.B. Olson, and D.S. Milliner Pyridoxine effect in type 1 primary hyperoxaluria is associated with the most common mutant allele Kidney Int 67 2005 1704 1709 (Pubitemid 40577704)
24. C.J. Danpure, and G. Rumsby Enzymological and molecular genetics of primary hyperoxaluria type 1. Consequences for clinical management S.R. Khan, Calcium oxalate in biological systems. 1995 CRC Press Boca Raton 189-205
25. L. Collard, A. Amore, A. Bensman, F. Bouissou, G. Bourdat, and J. de Ville de Goyet Combined liver kidney transplantation in children: multicentre report Pediatr Nephrol 21 2006 1514
26. N.V. Jamieson An update from the European PH1 liver/kidney transplant registry: short and long-term outcomes Urol Res 35 2007 258
27. D.M. Cibrik, B. Kaplan, J.A. Arnodorfer, and H.U. Meier-Kriesche Renal allograft survival in patients with oxalosis Transplantation 74 2002 707 710
28. M.T. Millan, W.E. Berquist, S.K. So, M.M. Sarwal, K.I. Wayman, and K.L. Cox One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience Transplantation 76 2003 1458 1463 (Pubitemid 37467694)
29. N.V. Jamieson A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria: the European PH1 transplant registry experience 1984-2004 Am J Nephrol 25 2005 282 289 (Pubitemid 41202752)
30. P. Cochat, and K. Schärer Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type 1? Pediatr Nephrol 7 1993 212 218 (Pubitemid 23093712)
31. M.J. Kemper The role of preemptive liver transplantation in primary hyperoxaluria type 1 Urol Res 33 2005 376 379 (Pubitemid 41752060)
32. P. Cochat Preemptive liver transplantation for primary hyperoxaluria Acta Gatroenterol Belg 68 2005 481 483
33. Y. Inoue, H. Masuyama, H. Ikawa, H. Mitsubuchi, and T. Kuhara Monitoring method for pre- and post-liver transplantation in patients with primary hyperoxaluria type 1 J Chromatogr B Analyt Technol Biomed Life Sci 792 2003 89 97 (Pubitemid 36773805)
34. M.F. Gagnadoux, F. Lacaille, P. Niaudet, Y. Revillon, P. Jouvet, and D. Jan Long-term results of liver-kidney transplantation in children with primary hyperoxaluria Pediatr Nephrol 16 2001 946 950 (Pubitemid 34026701)
35. C.G. Monico, and D.S. Milliner Combined liver-kidney and kidney-alone transplantation in primary hyperoxaluria Liver Transpl 7 2001 954 963 (Pubitemid 33085784)
36. I. Malla, P. Lysy, N. Godefroid, F. Smets, J. Malaise, and R. Reding Two-step transplantation for primary hyperoxaluria: cadaveric liver followed by living donor related kidney transplantation Pediatr Transplant 13 6 2009 782 784
37. H. Sidhu, B. Hoppe, A. Hesse, K. Tenbrock, S. Bromme, and E. Rietschel Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria Lancet 352 1998 1026 1029 (Pubitemid 28438575)
38. C. Campieri, M. Campieri, V. Bertuzzi, E. Swennen, D. Matteuzzi, and S. Stefoni Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration Kidney Int 60 2001 1097 1105 (Pubitemid 34205810)
39. B. Hoppe, G. von Unruh, N. Gatter, A. Hesse, and H. Sidhu Treatment with Oxalobacter formigenes is a new therapeutic option in patients with primary hyperoxaluria [abstract] J Am Soc Nephrol 14 2003 454A
40. H. Sidhu, P. Kaul, and B. Hoppe Oxabact™: a potential treatment for primary hyperoxaluria Urol Res 35 2007 261
41. S.V. Chetyrkin, D. Kim, J.M. Belmont, J.I. Scheinman, B.G. Hudson, and P.A. Voziyan Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria Kidney Int 67 2004 53 60 (Pubitemid 40019225)
42. B.C. Shenoy, D. Grujic, E.C. Salido, A. Torres, and A.L. Margolin Efficacy of oral crystalline enzyme in a mouse genetic model for primary hyperoxaluria Urol Res 35 2007 261
43. C.J. Danpure Primary hyperoxaluria: from gene defects to designer drugs? Nephrol Dial Transplant 20 2005 1525 1529 (Pubitemid 41418571)
44. A. Pittman, E. Hopper, M. Fitzgerald, and C. Tucker Yeast-based screen for AGT chemical chaperones Urol Res 35 2007 259
45. J. Jiang, E. Salido, C. Guha, X. Wang, N. Roy-Chowdhury, and J. Roy-Chowdhury Hepatocyte transplantation for the treatment of primary hyperoxaluria 1 in mouse model Urol Res 35 2007 260
46. S. Koul, T. Johnson, S. Pramanik, and H. Koul Cellular transfection to deliver alanine-glyoxylate aminotransferase to hepatocytes: a rational gene therapy for primary hyperoxaluria-1 Am J Nephrol 25 2005 176 182 (Pubitemid 40864187)
47. Y. Lu, X. Wang, E. Salido, C. Guha, J. Roy-Chowdhury, and N. Roy-Chowdhury Perturbation of the amino-terminal sequence of human mutant alanine: glyoxylate aminotransferase corrects the mistargeting of the protein and restores its physiological function Urol Res 35 2007 264
48. S.A. Johnson, G. Rumsby, D. Cregeen, and S.A. Hulton Primary hyperoxaluria type 2 in children Pediatr Nephrol 17 2002 597 601 (Pubitemid 36104160)
49. D.S. Milliner, D.M. Wilson, and L.H. Smith Phenotypic expression of primary hyperoxaluria: comparative features of types I and II Kidney Int 59 2001 31 36 (Pubitemid 32055211)
50. C.F. Giafi, and G. Rumsby Kinetic analysis and tissue distribution of human D-glycerate dehydrogenase/glyoxylate reductase and its relevance to the diagnosis of primary hyperoxaluria type 2 Ann Clin Biochem 35 1998 104 109 (Pubitemid 28043633)
51. M.P. Booth, R. Conners, G. Rumsby, and R.L. Brady Structural basis for the substrate specificity in human glyoxylate reductase/hydroxypyruvate reductase Urol Res 35 2007 265
52. R. Belostotsky, E. Seboun, G.H. Idelson, D.S. Milliner, R. Becker-Cohen, and C. Rinat Mutations in DHDPSL are responsible for primary hyperoxaluria type III Am J Hum Genet 87 2010 392 399